This new FDA-approved shot is designed to break down the barriers that have kept too many people from accessing PrEP.

Merck MRK announced that the FDA has accepted for review the new drug application (“NDA”) seeking approval for its investigational, once-daily, oral, two-drug, single-tablet regimen of ...

Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...

Borey and Sophia are among the first clients in Cambodia to begin long-acting injectable Cabotegravir (CAB-LA), a PrEP ...

Preventative therapies for HIV-1 (Human Immunodeficiency Virus type 1) have made leaps and bounds over the past decade. A ...

Analysts believe that Gilead's new PrEP drug Yeztugo could reach peak sales of $4.5 billion. Not if GSK has anything to say ...

The FDA has approved a breakthrough preventative treatment for HIV that could change the course of the AIDS epidemic. But ...

President Donald Trump's budget proposal for fiscal year 2026 requests significant reductions to HIV prevention and ...

Over the past three decades, there have been amazing advances in treating and preventing HIV. Subscribe to our newsletter for ...

Since 1995, National HIV Testing Day has raised awareness and confronted stereotypes about HIV. Learn about HIV testing options and prevention methods.

One study suggested that HIV psychosis may be a harbinger of dementia, [97] and another suggested that it was associated with decreased survival time. [98, 101] ...